Currently, in Ireland, the High Tech drugs scheme is administered by the HSE through the Primary Care Reimbursement Service (PCRS). The PCRS is aiming to introduce a fully electronic purchasing and stock control system, called the High Tech Hub (HTH), aimed to be a “one-stop-shop” for pharmacies for all high tech medicine orders.
The HTH will implement a new streamlined process for ordering high-tech drugs whereby patients can collect their treatments from their local pharmacy, rather than from hospitals.
The expenditure for these medicines exceeded €600 million for the first time in 2016 and is likely to reach €700 million in 2017. The HTH will help monitor patient data, tracking prescriptions and minimise wastage and over-ordering.
The HTH will be phased in starting in December 2017, with a focus on IVF treatments.
For more information, see the circular email from HSE here.